Loading…
Based on limited metadata, Premier Nutra Pharma Inc. received an FDA Warning Letter on December 9, 2022, regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. Additional documentation would be needed to detail the specific compliance violations cited.